お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:シングルセルマルチオミクスの世界市場 (2020-2025年):市場予測 (製品タイプ・オミクスタイプ・サンプルタイプ・技術・用途・エンドユーザー・地域別)・競合環境
市場調査レポート
商品コード
990083

シングルセルマルチオミクスの世界市場 (2020-2025年):市場予測 (製品タイプ・オミクスタイプ・サンプルタイプ・技術・用途・エンドユーザー・地域別)・競合環境

Global Single-Cell Multi-Omics Market (2020-2025): Focus on Product Type, Omics Type, Sample Type, Technique, Application, End User, Region, and Competitive Landscape - Analysis and Forecast, 2020-2025

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 228 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.72円
シングルセルマルチオミクスの世界市場 (2020-2025年):市場予測 (製品タイプ・オミクスタイプ・サンプルタイプ・技術・用途・エンドユーザー・地域別)・競合環境
出版日: 2021年02月17日
発行: BIS Research Inc.
ページ情報: 英文 228 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のシングルセルマルチオミクスの市場規模は予測期間中21.16%のCAGRで推移し、2025年には31億8890万米ドルの規模に成長すると予測されています。がん、希少疾患、細胞生物学、合成生物学など、さまざまな用途の臨床研究に向けた単細胞技術による先進ソリューションへのニーズが拡大しており、同市場の成長を牽引しています。

当レポートでは、世界のシングルセルマルチオミクスの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、製品タイプ・オミクスタイプ・サンプルタイプ・技術・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

エグゼクティブサマリー

第1章 製品の定義

第2章 調査範囲

第3章 調査手法

第4章 市場概要

  • シングルセルシーケンシングにおける技術開発

第5章 市場力学

  • 概要
  • 影響分析
  • 市場成長推進因子
  • 市場成長抑制因子
  • 市場機会

第6章 競合分析

  • 企業シェア分析
  • 成長シェア分析・市場機会マッピング

第7章 市場分析・予測:製品タイプ別

  • 機器
  • 消耗品
  • ソフトウェア

第8章 市場分析・予測:オミクスタイプ別

  • 単一細胞ゲノミクス
  • 単一細胞トランスクリプトミクス
  • 単一細胞プロテオミクス

第9章 市場分析・予測:サンプルタイプ別

  • ヒト
    • がん組織
    • 幹細胞
    • 脳細胞
    • 免疫細胞
    • その他
  • 動物
  • 微生物

第10章 市場分析・予測:技術別

  • 単一細胞分離・ディスペンシング
    • 蛍光活性化セルソーティング(FACS)
    • 手動セルピッキング
    • 磁気活性化セルソーティング(MACS)
    • レーザーキャプチャーマイクロダイセクション
    • ランダムシード
    • マイクロ流体
    • その他
  • 単一細胞分析
    • マスサイトメトリー
    • ポリメラーゼ連鎖反応
    • 次世代シーケンシング
    • 質量分析
    • その他

第11章 市場分析・予測:用途別

  • 臨床研究
    • 腫瘍
    • 免疫
    • 神経
    • 細胞療法
    • 細胞生物学
    • その他
  • トランスレーショナル研究
  • 合成生物学

第12章 市場分析・予測:エンドユーザー別

  • 概要
  • 研究機関・学術機関
  • CRO
  • バイオ医薬品・バイオテクノロジー企業
  • その他

第13章 市場分析・予測:地域・主要国別

  • 概要
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • シンガポール
    • インド
    • 中国
    • オーストラリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • その他
  • その他の地域

第14章 企業プロファイル

  • 1CellBio, Inc.
  • Fluidigm Corporation
  • 10x Genomics, Inc.
  • NanoString Technologies, Inc.
  • Bio-Techne Corporation
  • Bio-Rad Laboratories, Inc.
  • Mission Bio
  • Dolomite Bio
  • Fluxion Biosciences
  • Berkeley Lights, Inc.
  • RareCyte, Inc.
  • Becton, Dickinson and Company
  • Takara Bio, Inc.
  • Thermo Fisher Scientific Inc.
  • Namocell, Inc.

第15章 新興企業プロファイル

  • Proteona
  • BioTuring, Inc.
  • Scipio Biosciences SAS
  • Parse Biosciences, Inc.
  • Shilps Sciences
図表

List of Tables

  • Table 1: Per Sample Clinical Cost of WGS and WES
  • Table 5.1: Likert Scale
  • Table 5.2: Impact Analysis of Market Drivers
  • Table 5.3: Impact Analysis of Market Restraints
  • Table 5.4: Per Sample Clinical Cost of WGS and WES
  • Table 7.1: Single-Cell Multi-Omics Market (Instruments)
  • Table 7.2: Single-Cell Multi-Omics Market (Consumables)
  • Table 7.3: Single-Cell Multi-Omics Market (Software)
  • Table 10.1: Products for Fluorescence-Activated Cell Sorting
  • Table 10.2: Products for Manual Cell Picking
  • Table 10.3: Products for Magnetic-Activated Cell Sorting
  • Table 10.4: Products for Laser Microdissection
  • Table 10.5: Products for Random Seeding/Limited Dilution
  • Table 10.6: Products for Microfluidics

List of Figures

  • Figure 1: Impact Analysis of Market Drivers and Market Challenges on Global Single-Cell Multi-Omics Market
  • Figure 2: Global Single-Cell Multi-Omics Market (by Product Type), $Million, 2020 vs. 2025
  • Figure 3: Global Single-Cell Multi-Omics Market (by Application), $Million, 2020 vs. 2025
  • Figure 4: Global Single-Cell Multi-Omics Market (by Omics Type), $Million, 2020 vs. 2025
  • Figure 5: Global Single-Cell Multi-Omics Market (by Technique), $Million, 2020 vs. 2025
  • Figure 6: Global Single-Cell Multi-Omics Market (by Sample Type), $Million, 2020 vs. 2025
  • Figure 7: Global Single-Cell Multi-Omics Market (by End User), $Million, 2020 vs. 2025
  • Figure 8: Global Single-Cell Multi-Omics Market Snapshot
  • Figure 3.1: Primary Research Methodology
  • Figure 3.2: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.3: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: Single-Cell Multi-Omics Approach
  • Figure 4.2: Evolution of Single-Cell Multi-Omics Technology
  • Figure 4.4: Three Major Technological Developments in Single-Cell Sequencing
  • Figure 4.5: Traditional and Modern Approaches for Single-Cell Isolation
  • Figure 5.1: U.S. Prevalence of Lyme Disease 2009-2018
  • Figure 5.2: Global Prevalence Rate of Selected Rare Diseases Per 100,000 People
  • Figure 6.1: Market Share Analysis for the Global Single-Cell Multi-Omics Market, 2019
  • Figure 6.2: Growth Share Matrix for Global Single-Cell Multi-Omics Market (by Company), 2019
  • Figure 7.1: Global Single-Cell Multi-Omics Market (by Product Type)
  • Figure 7.2: Global Single-Cell Multi-Omics Market (Instruments), 2019-2025
  • Figure 7.3: Global Single-Cell Multi-Omics (Consumables), $Million, 2019-2025
  • Figure 7.4: Global Single-Cell Multi-Omics Market (Software), $Million, 2019-2025
  • Figure 8.1: Types of Omics Platforms
  • Figure 8.2: Global Single-Cell Genomics Market, $Million, 2019-2025
  • Figure 8.3: Global Single-Cell Transcriptomics Market, $Million, 2019-2025
  • Figure 8.4: Global Single-Cell Proteomics Market, $Million, 2019-2025
  • Figure 9.1: Global Single-Cell Multi-Omics Market (by Sample Type), $Million, 2019-2025
  • Figure 9.2: Global Single-Cell Multi-Omics Market (Human Samples), $Million, 2019-2025
  • Figure 9.3: Global Single-Cell Multi-Omics Market (Cancer Tissue), $Million, 2019-2025
  • Figure 9.4: Global Single-Cell Multi-Omics Market (Stem Cells), $Million, 2019-2025
  • Figure 9.5: Global Single-Cell Multi-Omics Market (Brain Cells), $Million, 2019-2025
  • Figure 9.6: Global Single-Cell Multi-Omics Market (Immune Cells), $Million, 2019-2025
  • Figure 9.7: Global Single-Cell Multi-Omics Market (Other Samples), $Million, 2019-2025
  • Figure 9.8: Global Single-Cell Multi-Omics Market (Animal Samples), $Million, 2019-2025
  • Figure 9.9: Global Single-Cell Multi-Omics Market (Microbial Samples), $Million, 2019-2025
  • Figure 10.1: Global Single-Cell Multi-Omics Market (by Technique)
  • Figure 10.2: Global Single-Cell Multi-Omics (Single-Cell Isolation and Dispensing), $Million, 2019-2025
  • Figure 10.3: Global Single-Cell Multi-Omics Market (FACS), $Million, 2019-2025
  • Figure 10.4: Global Single-Cell Multi-Omics Market (Manual Cell Picking), $Million, 2019-2025
  • Figure 10.5: Global Single-Cell Multi-Omics Market (MACS), $Million, 2019-2025
  • Figure 10.6: Global Single-Cell Multi-Omics Market (LCM), $Million, 2019-2025
  • Figure 10.7: Global Single-Cell Multi-Omics Market (Random Seeding), $Million, 2019-2025
  • Figure 10.8: Global Single-Cell Multi-Omics Market (Microfluidics), $Million, 2019-2025
  • Figure 10.9: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
  • Figure 10.10: Global Single-Cell Multi-Omics (Single-Cell Analysis), $Million, 2019-2025
  • Figure 10.11: Global Single-Cell Multi-Omics Market (Mass Cytometry), $Million, 2019-2025
  • Figure 10.12: Global Single-Cell Multi-Omics Market (Polymerase Chain Reaction), $Million, 2019-2025
  • Figure 10.13: Global Single-Cell Multi-Omics Market (Next-Generation Sequencing), $Million, 2019-2025
  • Figure 10.14: Global Single-Cell Multi-Omics Market (Mass Spectrometry), $Million, 2019-2025
  • Figure 10.15: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
  • Figure 11.1: Global Single-Cell Multi-Omics Market (Clinical Research), $Million, 2019-2025
  • Figure 11.2: Global Single-Cell Multi-Omics Market (Oncology), $Million, 2019-2025
  • Figure 11.3: Global Single-Cell Multi-Omics Market (Immunology), $Million, 2019-2025
  • Figure 11.4: Global Single-Cell Multi-Omics Market (by Neurology), $Million, 2019-2025
  • Figure 11.5: Global Single-Cell Multi-Omics Market (Cell Therapy), $Million, 2019-2025
  • Figure 11.6: Global Single-Cell Multi-Omics Market (Cell Biology), $Million, 2019-2025
  • Figure 11.7: Global Single-Cell Multi-Omics Market (Others), $Million, 2019-2025
  • Figure 11.8: Global Single-Cell Multi-Omics Market (Translational Research), $Million, 2019-2025
  • Figure 11.9: Global Single-Cell Multi-Omics Market (Synthetic Biology), $Million, 2019-2025
  • Figure 12.1: Global Single-Cell Multi-Omics Market (Research and Academia), $Million, 2019-2025
  • Figure 12.2: Global Single-Cell Multi-Omics Market (Contract Research Organizations), $Million, 2019-2025
  • Figure 12.3: Global Single-Cell Multi-Omics Market (Biopharmaceutical and Biotech Companies), $Million, 2019-2025
  • Figure 12.4: Global Single-Cell Multi-Omics Market (Other End Users), $Million, 2019-2025
  • Figure 13.1: Global Single-Cell Multi-Omics Market (by Region), $Million, 2020 and 2025
  • Figure 13.2: Global Single-Cell Multi-Omics Market (by Region), $Million, 2019-2025
  • Figure 13.3: North America Global Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.4: North America: Market Dynamics
  • Figure 13.5: North America Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
  • Figure 13.6: U.S. Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.7: Canada Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.8: Europe Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.9: Europe: Market Dynamics
  • Figure 13.10: Europe Global Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
  • Figure 13.11: Germany Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.12: France Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.13: U.K. Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.14: Italy Single-Cell Multi-Omics Market, $Millions, 2019-2025
  • Figure 13.15: Spain Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.16: Rest-of-Europe Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.17: Asia-Pacific Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.18: APAC: Market Dynamics
  • Figure 13.19: APAC Single-Cell Multi-Omics Market (by Country), $Million, 2019-2025
  • Figure 13.20: Japan Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.21: Singapore Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.22: India Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.23: China Single-Cell Multi-Omics Market, 2019-2025
  • Figure 13.24: Australia Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.25: RoAPAC Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.26: Latin America Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.27: Latin America: Market Dynamics
  • Figure 13.28: Latin America Single-Cell Multi-Omics Market (by Country), 2019-2025
  • Figure 13.29: Mexico Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.30: Brazil Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.31: Rest-of-Latin America Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 13.32: RoW Single-Cell Multi-Omics Market, $Million, 2019-2025
  • Figure 14.1: Total Number of Companies Profiled
  • Figure 14.2: 1CellBio, Inc.: Product Portfolio
  • Figure 14.3: 1CellBio: SWOT Analysis
  • Figure 14.4: Fluidigm Corporation: Product Portfolio
  • Figure 14.5: Fluidigm Corporation: Overall Financials, 2017-2019
  • Figure 14.6: Fluidigm Corporation: Revenue (by Business Segment), 2017-2019
  • Figure 14.7: Fluidigm Corporation.: Revenue (by Region), 2017-2019
  • Figure 14.8: Fluidigm Corporation: R&D Expenditure, 2017-2019
  • Figure 14.9: Fluidigm Corporation: SWOT Analysis
  • Figure 14.10: 10x Genomics, Inc.: Product Portfolio
  • Figure 14.11: 10x Genomics, Inc.: Overall Financials, 2017-2019
  • Figure 14.12: 10x Genomics, Inc.: Revenue (by Business Segment), 2017-2019
  • Figure 14.13: 10x Genomics, Inc.: Revenue (by Region), 2017-2019
  • Figure 14.14: 10x Genomics, Inc.: R&D Expenditure, 2017-2019
  • Figure 14.15: 10x Genomics, Inc.: SWOT Analysis
  • Figure 14.16: NanoString Technologies, Inc.: Product Portfolio
  • Figure 14.17: NanoString Technologies, Inc.: Overall Financials, 2017-2019
  • Figure 14.18: NanoString Technologies, Inc.: Revenue (by Business Segment), 2017-2019
  • Figure 14.19: NanoString Technologies, Inc.: Revenue (by Region), 2017-2019
  • Figure 14.20: NanoString Technologies, Inc.: R&D Expenditure, 2017-2019
  • Figure 14.21: NanoString Technologies, Inc.: SWOT Analysis
  • Figure 14.22: Bio-Techne Corporation: Product Portfolio
  • Figure 14.23: Bio-Techne Corporation: Overall Financials, 2020-2020
  • Figure 14.24: Bio-Techne Corporation: Revenue (by Business Segment), 2020-2020
  • Figure 14.25: Bio-Techne Corporation: Revenue (by Region), 2020-2020
  • Figure 14.26: Bio-Techne Corporation: R&D Expenditure, 2020-2020
  • Figure 14.27: Bio-Techne Corporation: SWOT Analysis
  • Figure 14.28: Bio-Rad Laboratories, Inc.: Product Portfolio
  • Figure 14.29: Bio-Rad Laboratories, Inc.: Overall Financials, 2017-2019
  • Figure 14.30: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2017-2019
  • Figure 14.31: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2017-2019
  • Figure 14.32: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2017-2019
  • Figure 14.33: Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 14.34: Mission Bio: Product Portfolio
  • Figure 14.35: Mission Bio: SWOT Analysis
  • Figure 14.36: Dolomite Bio: Product Portfolio
  • Figure 14.37: Dolomite Bio: SWOT Analysis
  • Figure 14.38: Fluxion Biosciences, Inc.: Product Portfolio
  • Figure 14.39: Fluxion Biosciences, Inc.: SWOT Analysis
  • Figure 14.40: Berkeley Lights, Inc.: Product Portfolio
  • Figure 14.41: Berkeley Lights, Inc.: Overall Financials, 2019-2020
  • Figure 14.42: Berkeley Lights, Inc.: Revenue (by Segment), 2018-2019
  • Figure 14.43: Berkeley Lights, Inc.: R&D Expenditure, 2017-2019
  • Figure 14.44: Berkeley Lights, Inc.: SWOT Analysis
  • Figure 14.45: RareCyte, Inc.: Overall Product Portfolio
  • Figure 14.46: RareCyte, Inc.: SWOT Analysis
  • Figure 14.47: Becton, Dickinson and Company: Product Portfolio
  • Figure 14.48: Becton, Dickinson and Company: Overall Financials, 2020-2020
  • Figure 14.49: Becton, Dickinson and Company: Revenue (by Business Segment), 2018-2020
  • Figure 14.50: Becton, Dickinson and Company: Revenue (by Region), 2018-2020
  • Figure 14.51: Becton, Dickinson and Company: R&D Expenditure, $Million, 2018-2020
  • Figure 14.52: Becton, Dickinson and Company: SWOT Analysis
  • Figure 14.53: Takara Bio, Inc.: Product Portfolio
  • Figure 14.54: Takara Bio Inc.: Overall Financials, (2018-2020)
  • Figure 14.55: Takara Bio, Inc.: Revenue (by Business Segment), 2018-2020
  • Figure 14.56: Takara Bio, Inc.: Revenue (by Region), 2019-2020
  • Figure 14.57: Takara Bio, Inc., R&D Expenditure, 2018-2020
  • Figure 14.58: Takara Bio Inc.: SWOT Analysis
  • Figure 14.59: Thermo Fisher Scientific, Inc.: Product Portfolio
  • Figure 14.60: Thermo Fisher Scientific Inc.: Overall Financials, 2017-2019
  • Figure 14.61: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2017-2019
  • Figure 14.62: Thermo Fisher Scientific Inc.: Revenue (by Region), 2017-2019
  • Figure 14.63: Thermo Fisher Scientific Inc.: R&D Expenditure (2017-2019)
  • Figure 14.64: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 14.65: Namocell, Inc.: Product Portfolio
  • Figure 14.66: Namocell, Inc.: SWOT Analysis
  • Figure 15.1: Proteona: Product Portfolio
  • Figure 15.2: BioTuring, Inc.: Product Portfolio
  • Figure 15.3: Parse Biosciences, Inc.: Product Portfolio
  • Figure 15.4: Shilps Sciences: Product Portfolio
目次
Product Code: BHP0714SB

"Global Single-Cell Multi-Omics Market to Reach $3,188.9 Million by 2025."

Market Report Coverage - Single-Cell Multi-Omics

Market Segmentation

  • Product Type - Consumables, Instruments, and Software
  • Sample Type - Human Samples, Animal Samples, and Microbial Samples
  • Omics Type - Single-Cell Transcriptomics, Single-Cell Genomics, Single-Cell Proteomics
  • Application - Clinical Research, Translational Research, and Synthetic Biology
  • Technique - Single-Cell Isolation and Dispensing and Single-Cell Analysis
  • End User - Academic and Research Institutions, Biopharmaceutical and Biotechnological Companies, Contract Research Organizations, and Other End Users

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, France, Italy, U.K., Spain, and Rest-of-Europe
  • Asia-Pacific - China, Japan, India, Singapore, Australia, and Rest-of-Asia-Pacific (RoAPAC)
  • Latin America - Brazil, Mexico, and Rest-of-the-Latin America
  • Rest-of-the-World

Growth Drivers

  • Increasing number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (sc-RNA)
  • Increasing Adoption of Personalized Medicine for the Screening and Diagnostics of Genetic Disorders
  • Increasing Disposable Income in Emerging Economies

Market Restraints

  • High Cost of Single-Cell Analysis and Integration of Data
  • Limited Availability of Large Online Data Storage and Analysis Platforms

Market Opportunities

  • Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
  • Requirement for the Development of Advanced Solutions Based on Single-Cell Technology
  • Increased Use of Single-Cell Technology Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
  • Expansion into New Research Application such as Single-Cell Metabolomics

Key Companies Profiled:

1CellBio, Inc., Fluidigm Corporation, 10x Genomics, Inc., NanoString Technologies, Inc., Bio-Techne Corporation, Bio-Rad Laboratories, Inc., Mission Bio, Dolomite Bio, Fluxion Biosciences, Berkeley Lights, Inc., RareCyte, Inc., Becton, Dickinson and Company, Takara Bio, Inc., Thermo Fisher Scientific Inc., Namocell, Inc.

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global single-cell multi-omics market?
  • What is the potential impact of biotechnological advancements in the diagnostic industry among end users such as researchers, pathologists, and laboratory technicians?
  • What is the current market demand along with future expected demand for the global single-cell multi-omics market?
  • What are the key development strategies that are implemented by the major players in order to sustain the competitive market?
  • How is each segment of the market expected to grow during the forecast period from 2020 to 2025 based on the following segments:
    • product type
    • omics type
    • technique
    • sample type
    • application
    • end user
    • region, namely North America, Europe, Asia-Pacific, Rest-of-the-World (RoW)
  • Which are the leading players with significant offerings to the global single-cell multi-omics market? What is the expected market dominance for each of these leading players?
  • Which emerging companies are anticipated to be highly disruptive in the future, and what are their key strategies for sustainable growth in the global single-cell multi-omics market?

Market Overview

BIS Research healthcare experts have found the single-cell multi-omics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 21.16% during the forecast period, 2020-2025. The market is driven by the need for the development of an advanced solution based on single-cell technology for clinical research in various applications such as cancer, rare disease, cell biology, and synthetic biology, among others.

The market is favored by the development of single-cell technology-based solutions for visualization and analysis of cell heterogeneity, tumor microenvironment, and antibody development. The gradual increase in the prevalence of oncology and rare diseases globally has furthered the single-cell multi-omics market.

Furthermore, several contract research organizations are focusing on the development of single-cell technology-based services, which enable simultaneous analysis of genomics, proteomics, and transcriptomics, providing deeper insights on a disease progression.

Within the research report, the market is segmented on the basis of product type, sample type, omics type, technique, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of high-resolution multiplex diagnostics providing information on cellular interaction and tissue heterogeneity to understand disease biology and pathology. Due to technologically advanced solutions and intense market penetration, 10x Genomics, Inc. has been a pioneer and a significant competitor in this market.

Other key players in the market are NanoString Technologies, Inc., RareCyte, Inc., Fluidigm Corporation, Becton, Dickinson and Company, Thermo Fisher Sciences, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Namocell, Inc., 1Cell Bio, Inc., Mission Bio, Berkeley Lights, Takara Bio, Inc., Dolomite Bio, and Bio-Techne Corporation.

On the basis of region, North America holds the largest share of the single-cell multi-omics market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Asia-Pacific is anticipated to grow at the fastest CAGR of 21.53% during the forecast period 2020-2025.

The market utilizes several technologies, such as barcoding, sequencing, mass cytometry, and microscopy, for the development of instruments and assays for single-cell analysis of tissue and cells to gain an understanding of cell heterogeneity and cellular mechanism. Each solution offered by the leading players is the combination of next-generation omics tools for application in several clinical areas, such as oncology, neurology, immunology, and pathology.

Table of Contents

Executive Summary

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Scope of Work

  • 2.1 Scope of the Study
  • 2.2 Key Questions Addressed in the Report

3 Research Methodology

  • 3.1 Primary Data Sources
  • 3.2 Secondary Data Sources
  • 3.3 Market Estimation Model
  • 3.4 Criteria for Company Profiling

4 Market Overview

  • 4.1 Introduction
    • 4.1.1 Technological Development in Single-Cell Sequencing
      • 4.1.1.1 Advancements in Imaging Techniques for Single-Cell Sequencing
      • 4.1.1.2 Advancements in Single-Cell Collection and Analysis System

5 Market Dynamics

  • 5.1 Overview
  • 5.2 Impact Analysis
  • 5.3 Market Drivers
    • 5.3.1 Increasing number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (sc-RNA)
    • 5.3.2 Increasing Adoption of Personalized Medicine for the Screening and Diagnostics of Genetic Disorders
    • 5.3.3 Increasing Disposable Income in Emerging Economies
  • 5.4 Market Restraints
    • 5.4.1 High Cost of Single-Cell Analysis and Integration of Data
    • 5.4.2 Limited Availability of Large Online Data Storage and Analysis Platforms
  • 5.5 Market Opportunities
    • 5.5.1 Massive Scope for Adoption of Genomic-Based Medicine in Emerging Nations
    • 5.5.2 Requirement for the Development of Advanced Solutions Based on Single-Cell Technology
    • 5.5.3 Increased Use of Single-Cell Technology Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
    • 5.5.4 Expansion into New Research Applications such as Single-Cell Metabolomics

6 Competitive Insights

  • 6.1 Market Share Analysis (by Company), 2019
  • 6.2 Growth Share Analysis (Opportunity Mapping)
    • 6.2.1 By Company

7 Global Single-Cell Multi-Omics Market (by Product Type)

  • 7.1 Instruments
  • 7.2 Consumables
  • 7.3 Software

8 Global Single-Cell Multi-Omics Market (by Omics Type)

  • 8.1 Single-Cell Genomics
  • 8.2 Single-Cell Transcriptomics
  • 8.3 Single-Cell Proteomics

9 Global Single-Cell Multi-Omics Market (by Sample Type)

  • 9.1 Human Samples
    • 9.1.1 Cancer Tissues
    • 9.1.2 Stem Cells
    • 9.1.3 Brain Cells
    • 9.1.4 Immune Cells
    • 9.1.5 Other Samples
  • 9.2 Animal Samples
  • 9.3 Microbial Samples

10 Global Single-Cell Multi-Omics Market (by Technique)

  • 10.1 Single-Cell Isolation and Dispensing
    • 10.1.1 Fluorescence-Activated Cell Sorting (FACS)
    • 10.1.2 Manual Cell Picking
    • 10.1.3 Magnetic-Activated Cell Sorting (MACS)
    • 10.1.4 Laser Capture Microdissection
    • 10.1.5 Random Seeding
    • 10.1.6 Microfluidics
    • 10.1.7 Others
  • 10.2 Single-Cell Analysis
    • 10.2.1 Mass Cytometry
    • 10.2.2 Polymerase Chain Reaction
    • 10.2.3 Next-Generation Sequencing
    • 10.2.4 Mass Spectrometry
    • 10.2.5 Others

11 Global Single-Cell Multi-Omics Market (by Application)

  • 11.1 Clinical Research
    • 11.1.1 Oncology
    • 11.1.2 Immunology
    • 11.1.3 Neurology
    • 11.1.4 Cell Therapy
    • 11.1.5 Cell Biology
    • 11.1.6 Others
  • 11.2 Translation Research
  • 11.3 Synthetic Biology

12 Global Single-Cell Multi-Omics Market (by End User)

  • 12.1 Overview
  • 12.2 Research and Academic Laboratories
  • 12.3 Contract Research Organizations
  • 12.4 Biopharmaceutical and Biotech Companies
  • 12.5 Others End Users

13 Global Single-Cell Multi-Omics Market (by Region)

  • 13.1 Overview
    • 13.1.1 U.S.
    • 13.1.2 Canada
  • 13.2 Europe
    • 13.2.1 Germany
    • 13.2.2 France
    • 13.2.3 U.K.
    • 13.2.4 Italy
    • 13.2.5 Spain
    • 13.2.6 Rest-of-Europe
  • 13.3 Asia-Pacific
    • 13.3.1 Japan
    • 13.3.2 Singapore
    • 13.3.3 India
    • 13.3.4 China
    • 13.3.5 Australia
    • 13.3.6 Rest-of-APAC
  • 13.4 Latin America
    • 13.4.1 Mexico
    • 13.4.2 Brazil
    • 13.4.3 Rest-of-Latin America
  • 13.5 Rest-of-the-World

14 Company Profiles

  • 14.1 Overview
  • 14.2 1CellBio, Inc.
    • 14.2.1 Company Overview
    • 14.2.2 Role of 1CellBio, Inc. in the Global Single-Cell Multi-Omics Market
    • 14.2.3 SWOT Analysis
  • 14.3 Fluidigm Corporation
    • 14.3.1 Company Overview
    • 14.3.2 Role of Fluidigm Corporation in Global Single-Cell Multi-Omics Market
    • 14.3.3 Financials
    • 14.3.4 Key Insights About Financial Health of the Company
    • 14.3.5 SWOT Analysis
  • 14.4 10x Genomics, Inc.
    • 14.4.1 Company Overview
    • 14.4.2 Role of 10x Genomics, Inc. in Global Single-Cell Multi-Omics Market
    • 14.4.3 Financials
    • 14.4.4 Key Insights About Financial Health of the Company
    • 14.4.5 SWOT Analysis
  • 14.5 NanoString Technologies, Inc.
    • 14.5.1 Company Overview
    • 14.5.2 Role of NanoString Technologies, Inc. in Global Single-Cell Multi-Omics Market
    • 14.5.3 Key Insights About Financial Health of the Company
    • 14.5.4 SWOT Analysis
  • 14.6 Bio-Techne Corporation
    • 14.6.1 Company Overview
    • 14.6.2 Role of Bio-Techne Corporation in Global Single-Cell Multi-Omics Market
    • 14.6.3 Key Insights About Financial Health of the Company
    • 14.6.4 SWOT Analysis
  • 14.7 Bio-Rad Laboratories, Inc.
    • 14.7.1 Company Overview
    • 14.7.2 Role of Bio-Rad Laboratories, Inc. in Global Single-Cell Multi-Omics Market
    • 14.7.3 Financials
    • 14.7.4 Key Insights About Financial Health of the Company
    • 14.7.5 SWOT Analysis
  • 14.8 Mission Bio
    • 14.8.1 Company Overview
    • 14.8.2 Role of Mission Bio in the Single-Cell Multi-Omics Market
    • 14.8.3 SWOT Analysis
  • 14.9 Dolomite Bio
    • 14.9.1 Company Overview
    • 14.9.2 Role of Dolomite Bio in the Single-Cell Multi-Omics Market
    • 14.9.3 SWOT Analysis
  • 14.1 Fluxion Biosciences
    • 14.10.1 Company Overview
    • 14.10.2 Role of Fluxion Biosciences in the Global Single-Cell Multi-Omics Market
    • 14.10.3 SWOT Analysis
  • 14.11 Berkeley Lights, Inc.
    • 14.11.1 Company Overview
    • 14.11.2 Role of Berkeley Lights, Inc. in Global Single-Cell Multi-Omics Market
    • 14.11.3 Financials
    • 14.11.4 Key Insights About Financial Health of the Company
    • 14.11.5 SWOT Analysis
  • 14.12 RareCyte, Inc.
    • 14.12.1 Company Overview
    • 14.12.2 Role of RareCyte, Inc. in Global Single-Cell Multi-Omics Market
    • 14.12.3 SWOT Analysis
  • 14.13 Becton, Dickinson and Company
    • 14.13.1 Company Overview
    • 14.13.2 Role of Becton, Dickinson and Company in the Global Single-Cell Multi-Omics Market
    • 14.13.3 Key Insights About Financial Health of the Company
    • 14.13.4 SWOT Analysis
  • 14.14 Takara Bio, Inc.
    • 14.14.1 Company Overview
    • 14.14.2 Role of Takara Bio, Inc. in the Global Single-Cell Multi-Omics Market
    • 14.14.3 Key Insights About Financial Health of Company
    • 14.14.4 SWOT Analysis
  • 14.15 Thermo Fisher Scientific Inc.
    • 14.15.1 Company Overview
    • 14.15.2 Role of Thermo Fisher Scientific Inc. in Global Single-Cell Multi-Omics Market
    • 14.15.3 Financials
    • 14.15.4 Key Insights About Financial Health of the Company
    • 14.15.5 SWOT Analysis
  • 14.16 Namocell, Inc.
    • 14.16.1 Company Overview
    • 14.16.2 Role of Namocell, Inc. in the Single-Cell Multi-Omics Market
    • 14.16.3 SWOT Analysis

15 Emerging Companies

  • 15.1 Proteona
    • 15.1.1 Company Overview
    • 15.1.2 Role of Proteona in the Single-Cell Multi-Omics Market
  • 15.2 BioTuring, Inc.
    • 15.2.1 Company Overview
    • 15.2.2 Role of BioTuring, Inc. in the Single-Cell Multi-Omics Market
  • 15.3 Scipio Biosciences SAS
    • 15.3.1 Company Overview
    • 15.3.2 Role of Scipio Biosciences SAS in the Single-Cell Multi-Omics Market
  • 15.4 Parse Biosciences, Inc.
    • 15.4.1 Company Overview
    • 15.4.2 Role of Parse Biosciences, Inc. in the Single-Cell Multi-Omics Market
  • 15.5 Shilps Sciences
    • 15.5.1 Company Overview
    • 15.5.2 Role of Shilps Sciences in the Single-Cell Multi-Omics Market
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.